Physician profile
Michael N Gordon
NPI 1235240516
$529.76
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $125 · 2020: $39.42 · 2021: $147 · 2022: $37.57 · 2023: $22.90 · 2024: $158.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $181.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $180.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $203.96 | 2019-2022 | |
| Abiomed | $142.91 | 2024 | Impella |
| Teva Pharmaceuticals USA, INC. | $55.75 | 2020-2021 | |
| Novo Nordisk INC | $33.19 | 2021-2022 | |
| Biogen, INC. | $32.94 | 2021 | |
| Livanova USA, INC. | $22.90 | 2023 | Tandemlife |
| Acadia Pharmaceuticals INC | $15.10 | 2024 | Nuplazid |
| Amarin Pharma, INC. | $12.22 | 2019 | |
| Allergan, INC. | $10.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Gordon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.